Public say yes to new bowel cancer test

19 February 2013

The vast majority of people who have had a new bowel cancer test say they were glad to have done so and would encourage a friend to have it.

The test, called flexible sigmoidoscopy, will soon be included in the national screening programme in England as a one-off cancer diagnosis test for 55-year-olds.

The procedure uses a tiny camera on a thin flexible tube that is inserted into the bowel to look for small growths or 'polyps'.

A survey by Cancer Research UK of 1,020 people who had a flexible sigmoidoscopy test found 98 per cent were 'glad' to have it and just over 97 per cent would recommend it to a friend.

Dr Katie Robb, Cancer Research UK psychologist and lead author from the University of Glasgow, said: "The overwhelmingly positive response in our study suggests that people who are invited to have the new test from March this year are likely to have a similarly favourable experience."

The research was published in the Journal of Medical Screening.

Bowel cancer is the third most common cancer in men and the second most common in women.

Posted by Jeanette Royston

Health News is provided by Adfero in collaboration with Spire Healthcare. Please note that all copy above is ©Adfero Ltd. and does not reflect views or opinions of Spire Healthcare unless explicitly stated. Additional comments on the page from individual Spire consultants do not necessarily reflect the views or opinions of other consultants or Spire Healthcare.

Find a treatment, test or scan available at:

or

Find a consultant

Use one or more of the options below to search for a consultant and link through to view their Spire profile.

or

Let us help you

fill out this form and we will get back to you:

Please select a hospital

We can call you

Please enter your details below and we will call you back.

What is the aim of your enquiry?

Please select a hospital

If we are unable to reach you by phone, please include your email address so that we can get in touch...

Categories

Cancer

© Spire Healthcare Group plc (2016)